Obelysis
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
sodium chloride, Quantity: 4.61 g; glycerol, Quantity: 24.5 g
Available from:
Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific
INN (International Name):
glycerol,sodium chloride
Pharmaceutical form:
Injection, solution
Composition:
Excipient Ingredients: water for injections
Administration route:
Subcutaneous
Product summary:
Visual Identification: clear, colourless liquid; Container Type: Vial
Authorization status:
Licence status A
Authorization date:
2014-01-16
